Damon Technology Group Co.,Ltd. (SHA:688360)

Checkpoint Therapeutics Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,143	3,500	2,701	2,107	2,793	2,695
Market Cap Growth	80.85%	29.61%	28.19%	-24.57%	3.62%	-
Enterprise Value	6,082	3,369	2,582	1,888	2,600	2,399
Last Close Price	23.29	13.19	10.04	8.70	11.40	10.87
PE Ratio	59.28	37.83	30.84	25.79	36.35	40.57
PS Ratio	4.02	2.40	1.95	1.38	1.88	3.51
PB Ratio	4.31	2.52	2.02	2.12	2.99	3.03
P/TBV Ratio	6.40	3.78	3.15	2.28	3.07	3.12
P/FCF Ratio	1203.00	34.70	-	37.96	-	-
P/OCF Ratio	54.24	19.70	46.25	14.13	-	-
EV/Sales Ratio	3.98	2.31	1.87	1.23	1.75	3.13
EV/EBITDA Ratio	33.04	21.71	20.46	15.98	32.28	35.24
EV/EBIT Ratio	39.46	25.81	25.48	19.14	41.13	45.79
EV/FCF Ratio	1191.04	33.40	-	34.02	-	-
Debt / Equity Ratio	0.27	0.21	0.17	0.14	0.10	0.06
Debt / EBITDA Ratio	2.08	1.85	1.72	1.13	1.08	0.84
Debt / FCF Ratio	74.97	2.94	-	2.50	-	-
Asset Turnover	0.55	0.54	0.65	0.86	0.87	0.65
Inventory Turnover	2.51	2.92	3.40	2.54	2.15	1.67
Quick Ratio	1.31	1.31	1.52	1.44	1.07	1.22
Current Ratio	1.85	1.76	1.85	2.00	1.82	2.09
Return on Equity (ROE)	7.16%	6.53%	7.50%	8.47%	8.43%	10.62%
Return on Assets (ROA)	3.48%	3.03%	2.97%	3.48%	2.31%	2.79%
Return on Capital (ROIC)	5.69%	5.03%	4.71%	5.72%	4.01%	4.81%
Return on Capital Employed (ROCE)	8.20%	7.40%	6.20%	9.50%	6.50%	5.70%
Earnings Yield	1.68%	2.64%	3.24%	3.88%	2.75%	2.46%
FCF Yield	0.08%	2.88%	-0.56%	2.63%	-5.13%	-2.49%
Dividend Yield	0.46%	0.81%	1.27%	1.21%	0.86%	1.17%
Payout Ratio	40.27%	44.28%	34.22%	34.35%	42.73%	2.25%
Buyback Yield / Dilution	-0.92%	-5.63%	-6.28%	-0.51%	-11.81%	-19.27%
Total Shareholder Return	-0.45%	-4.82%	-5.01%	0.70%	-10.94%	-18.10%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.